Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Solana Beach, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Evoke Pharma Inc has filed 665 SEC EDGAR filings since 11 Jun 2007

SEC filing history

Showing 576-600 of 662 matching filings.

Per page
25
Current page
24
8-K File 001-36075

FORM 8-K

Filing date
28 May 2014
Reporting date
23 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 May 2014
Reporting date
20 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 May 2014
Reporting date
20 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 May 2014
Reporting date
20 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 May 2014
Reporting date
20 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 May 2014
Reporting date
20 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 May 2014
Reporting date
20 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

FORM 8-K

Filing date
21 May 2014
Reporting date
21 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

FORM 8-K

Filing date
13 May 2014
Reporting date
13 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36075

DEFA14A

Filing date
08 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36075

DEF 14A

Filing date
08 Apr 2014
Reporting date
20 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

FORM 8-K

Filing date
25 Mar 2014
Reporting date
25 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87872

SC 13G

Filing date
13 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

FORM 8-K

Filing date
07 Feb 2014
Reporting date
06 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87872

SCHEDULE 13G FOR EVOKE PHARMA, INC. BY DOMAIN PARTNERS VII, L.P.

Filing date
06 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

FORM 8-K

Filing date
31 Jan 2014
Reporting date
29 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Dec 2013
Reporting date
02 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Dec 2013
Reporting date
02 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Dec 2013
Reporting date
02 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
03 Dec 2013
Reporting date
01 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

FORM 8-K

Filing date
02 Dec 2013
Reporting date
01 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

FORM 8-K

Filing date
02 Dec 2013
Reporting date
25 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .